| ACS | Anorexia–cachexia syndrome |
| ANH | Assisted nutrition and hydration |
| ARC | Arcuate nucleus |
| ASPEN | American Society for Parenteral and Enteral Nutrition |
| α-MSH | Alpha-melanocyte-stimulating hormone |
| BBB | Blood–brain barrier |
| CANH | Clinically assisted nutrition and hydration |
| CNS | Central nervous system |
| COX | Cyclooxygenase |
| CRP | C-reactive protein |
| CSF | Cerebrospinal fluid |
| EAPC | European Association for Palliative Care |
| EN | Enteral nutrition |
| ESKD | End-stage kidney disease |
| ESPEN | European Society for Clinical Nutrition and Metabolism |
| GH/IGF-1 | Growth hormone/Insulin-like growth factor-1 axis |
| 5-HT2C | Serotonin receptor subtype 2C |
| IFN-γ | Interferon-gamma |
| IL-1 | Interleukin-1 |
| IL-6 | Interleukin-6 |
| LACDP | Leadership Alliance for the Care of Dying People |
| LMF | Lipid-mobilizing factor |
| MC4R | Melanocortin-4 receptor |
| NC | Nutritional counseling |
| NGT | Nasogastric tube |
| NPY | Neuropeptide Y |
| OCTGIR | One Chance to Get It Right |
| OIC | Opioid-induced constipation |
| ONS | Oral nutritional supplements |
| PEG | Percutaneous endoscopic gastrostomy |
| PEI | Pancreatic exocrine insufficiency |
| PGE2 | Prostaglandin E2 |
| PN | Parenteral nutrition |
| POMC | Proopiomelanocortin |
| QoL | Quality of life |
| SNPs | Single-nucleotide polymorphisms |
| TF | Tube feeding |
| TNF-α | Tumor Necrosis Factor-alpha |
| TP53, MYC, HIF1A | Tumor driver genes (oncogenes and transcription factors) |
| VMH | Ventromedial hypothalamic nucleus |
| VSED | Voluntary stopping of eating and drinking |